Latest Breaking News On - Chris hollowood - Page 2 : vimarsana.com

Form 20-F Achilles Therapeutics For: Dec 31

Form 20-F Achilles Therapeutics For: Dec 31
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Zabaykal skiy krayUnited statesCity of new yorkNew yorkEteläuomen läiNew zealandSouth koreaNorthern irelandUnited kingdomHong kongState of new yorkChannel islandsGuernsey generalCity ofNoord hollandNetherlands general

Syncona quarterly update: Net assets and portfolio value increase, key milestones achieved by portfolio companies

Syncona Limited has issued its quarterly update, reporting an increase in net assets and a positive NAV per share return. The company's life science portfolio also saw significant growth. Read more for details. #Syncona #quarterlyupdate #lifescienceinvestment

City ofUnited kingdomRolf soderstromKate butlerMartin murphyChris hollowoodVectura groupDrug administrationGilead sciences incUniversity of edinburghEvaluation committeeSyncona investment management limitedSyncona investment managementSyncona limitedAutolus therapeuticsBeacon therapeutics

Syncona portfolio strengthens in third quarter thanks to Autolus

Syncona Ltd on Thursday reported a recent increase to the value of its portfolio, as the company said it was in a strong position to push forward its main life science companies. For the third.

City ofUnited kingdomHugh cameronChris hollowoodSyncona ltd onAlliance newsAlliance news ltdAutolus therapeuticsDrug administrationExecutive officer chris hollowoodAll rights

Syncona says Freeline trial for Gaucher disease treatment positive

Syncona Ltd on Friday noted Freeline Therapeutics Holdings PLC s positive data for Gaucher disease treatment. The London-based investor in healthcare companies currently owns 49.7% of shares in.

City ofUnited kingdomChris hollowoodSyncona ltd onAlliance newsFreeline therapeutics holdingsAlliance news ltdChief executive officer chris hollowoodSabrina pentyAll rights

Syncona s portfolio company, Freeline, releases positive data on gene therapy for Gaucher disease

Syncona s portfolio company, Freeline, releases positive data on gene therapy for Gaucher disease
directorstalkinterviews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from directorstalkinterviews.com Daily Mail and Mail on Sunday newspapers.

Chris hollowoodExchange commissionFreeline therapeutics holdingsSyncona investment managementSyncona ltdScheme circularGeneral meetingSyncona investment management limited